Sigma‐1 Receptor‐Targeting Compounds Show Antiviral Activity Across Multiple Coronavirus Models
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.71123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Cuiling Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Jilin Province for Zoonoses Prevention and Control, State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical S…. Hauptthemen laut MEDLINE: Antiviral Agents, Receptors, sigma, SARS-CoV-2, COVID-19 Drug Treatment. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jilin Province Science and Technology Development Plan Youth Growth Science and Technology Project.
Abstract (Originalsprache)
Over the past two decades, coronaviruses have caused three major public health crises, including the epidemics of SARS‐CoV, MERS‐CoV , and SARS‐CoV‐2 . Following the outbreak of SARS‐CoV‐2 , several antiviral drugs have been approved for the treatment of COVID‐19. However, the high mutation rate of SARS‐CoV‐2 has led to the emergence of multiple variants, some of which can escape vaccine‐induced immunity and develop resistance to virus‐targeted drugs. Viruses rely on host cell mechanisms to complete replication and transmission. Host‐directed therapy is an emerging strategy that inhibits infection by targeting host cell factors essential for pathogen replication. Interventions targeting host factors have been proven effective in limiting viral infections and have the potential to reduce the risk of drug resistance. Our previous study found that the sigma‐1 receptor (σ1R) is involved in the autophagic process mediated by the SARS‐CoV‐2 non‐structural protein NSP6, suggesting that σ1R may serve as a therapeutic target against SARS‐CoV‐2 . In this study, we found that the σ1R antagonists BD‐1047 and σ1RA1 inhibited SARS‐CoV‐2 and its variants in vitro and showed antiviral activity in vivo . At the cellular level, these compounds also inhibited porcine epidemic diarrhea virus ( PEDV ) and infectious bronchitis virus ( IBV ), indicating cross‐model antiviral activity. BD‐1047 further showed antiviral activity against HCoV‐OC43 in both in vitro and in vivo models. In addition, Ocaperidone, identified through computer‐aided screening, exhibited protective effects against SARS‐CoV‐2 and HCoV‐OC43 in both cell‐based and mouse models. Collectively, these findings support σ1R as a host‐associated antiviral target candidate and provide several compounds for further optimization and mechanistic investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Jilin Province for Zoonoses Prevention and Control, State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Changchun, China.
- School of Pharmacy, Nantong University, Nantong, China.
- School of Life Sciences, Northeast Normal University, Changchun, China.
- Department of Chemistry, Northeastern University, Shenyang, China.
- Jiangxi Provincial Key Laboratory of Systems Biomedicine, Jiujiang University, Jiujiang, China.
- Zhejiang Key Laboratory of Environment and Health of New Pollutants, School of Environment, Hangzhou Institute for Advanced Study, University of Chinese Academy Sciences, Hangzhou, China.
ORCID-Profile: Gaojie Song, Gaoxing Su
Förderung
- Jilin Province Science and Technology Development Plan Youth Growth Science and Technology Project
Zitieren
APA
Zhang, C., Dong, X., Liu, J., Chen, M., Lin, L., Song, G., Xia, X., Su, G., Li, X., & Shang, C. (2026). Sigma‐1 Receptor‐Targeting Compounds Show Antiviral Activity Across Multiple Coronavirus Models. Journal of Medical Virology. https://doi.org/10.1002/jmv.71123
Vancouver
Zhang C, Dong X, Liu J, Chen M, Lin L, Song G, et al. Sigma‐1 Receptor‐Targeting Compounds Show Antiviral Activity Across Multiple Coronavirus Models. Journal of Medical Virology. 2026. doi:10.1002/jmv.71123
BibTeX
@article{Zhang2026,
author = {Zhang, Cuiling and Dong, Xingpeng and Liu, Jiaying and Chen, Minghua and Lin, Lisen and Song, Gaojie and Xia, Xianzhu and Su, Gaoxing and Li, Xiao and Shang, Chao},
title = {Sigma‐1 Receptor‐Targeting Compounds Show Antiviral Activity Across Multiple Coronavirus Models},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.71123}
}
EUVIMED